Seres Therapeutics GAAP EPS of -$1.63 misses by $0.63, revenue of $0.59M misses by $5.76M
Open the sourceReported by Seeking Alpha, seekingalpha.com, 4 November 2026
Not scored
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.